Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Herrington: The HERS trial results: paradigms lost?. (0.16 sec) 

The HERS trial results: paradigms lost?

- annals.org [PDF] 
DM Herrington - Annals of internal medicine, 1999 - Am Coll Physicians
The Heart and Estrogen/progestin Replacement Study (HERS) found no overall effect of 4.1
years of therapy with estrogen plus progestin for secondary prevention of coro- nary heart disease
in postmenopausal women. However, within the overall null effect, a 50% increase in ...
Cited by 109 - Related articles - BL Direct - All 8 versions

Результаты испытания HERS: не пора ли менять наш взгляд на показания к …


ДМ Херрингтон - mediasphera.ru
Результаты испытания HERS (Heart and Estrogen/progestin Replacement Study)
показали, что применение в течение 4 лет комбинированной заместительной гормональной
терапии (ЗГТ) эстрогенами и прогестином для вторичной профилактики ...
Related articles - All 2 versions

[PDF] The HERS Trial Results: Paradigms Lost?


NR Effect - Ann Intern Med, 1999 - biblioteca.sp.san.gva.es
The Heart and Estrogen/progestin Replacement Study (HERS) found no overall effect of 4.1
years of therapy with estrogen plus progestin for secondary prevention of coro- nary heart disease
in postmenopausal women. However, within the overall null effect, a 50% increase in ...
Related articles - View as HTML

Substitution hormonale et thromboses: leçons de ces cinq dernières années


SRFLF Boehlen, YDP de Moerloose - titan.medhyg.ch
L'hormonothérapie de substitution a démontré un bénéfice indiscutable dans le traitement des
symptômes climatériques de la ménopause et la prévention de l'ostéoporose. Jusqu'en
1996, il semblait que le risque de thrombose veineuse associé à la substitution ...
Related articles - Cached

Postmenopausal female hormone use and venous thromboembolic disease in …


L Rosenberg, JR Palmer, LL Adams-Campbell - American Journal of Obstetrics …, 1997 - Elsevier
On the basis of the 1995 questionnaire data, 422 postmenopausal women had had a “clot in
the leg or lungs” (cases) and 15,346 had not (controls). The age-adjusted odds ratio for female
hormone use (222 case and 7150 control users) was 1.4 (95% confidence interval 1.1 to ...
Cited by 4 - Related articles - BL Direct - All 4 versions

[CITATION] Risks and benefits of estrogen plus progestin in healthy postmenopausal women. …


KA Burry - Curr Women's Health Rep, 2002
Cited by 13 - Related articles

[PDF] Kardiovaskulare Aspekte der Hormonersatz-Therapie


P Pietschmann, J Grisar, S Travica - JOURNAL FUR MINERALSTOFFWECHSEL, 2002 - kup.at
P . b . b . GZ 0 2 Z 0 3 1 1 0 8 M , V erlagspostamt : 3 0 0 2 P urkersdorf , E rscheinungsort : 3
0 0 3 G ablitz ... P . b . b . GZ 0 2 Z 0 3 1 1 0 8 M , V erlagspostamt : 3 0 0 2 P urkersdorf , E rscheinungsort
: 3 0 0 3 G ablitz ... Österreichische Gesellschaft für Orthopädie und Orthopädische ...
Related articles - View as HTML - BL Direct - All 4 versions

Prostaglandin F 2a metabolite and F 2-isoprostane excretion rates in migraine


J Helmersson, P Mattsson, B Samar - Clinical Science, 2002 - cs.portlandpress.com
The pathophysiology theory of migraine postulates a local, neurogenic inflammation and the
possible involvement of oxidative stress. We analysed the levels of 15-oxo-dihydro-prostaglandin
F 2a (a metabolite of prostaglandin F 2a ) and 8-iso-prostaglandin F 2a (a major ...
Cited by 40 - Related articles - Cached - BL Direct - All 12 versions

The Heart and Estrogen/Progestin Replacement Study: what have we learned and …


G Wells, DM Herrington - Drugs &# 38; Aging, 1999 - ingentaconnect.com
Abstract The Heart and Estrogen/Progestin Replacement Study (HERS) was the first
randomised, double-blind, placebo-controlled study to evaluate the outcome of hormone replacement
therapy (HRT) on subsequent cardiac events in postmeno- pausal women with ...
Cited by 21 - Related articles - BL Direct - All 4 versions

Beyond the null hypothesis--do the HERS results disprove the estrogen/coronary …


RS Blumenthal, HA Zacur, SE Reis, WS Post - The American Journal of …, 2000 - Elsevier
HERS was the first prospective randomized, double-blind, placebo-controlled trial of the effects
of HRT (with conjugated estrogen and medoxyprogesterone acetate) on CHD risk. It enrolled
2,763 postmenopausal women (average age 67 years). Surprisingly, after 4 years of ...
Cited by 21 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google